Breaking News Instant updates and real-time market news.

2018-09-24 17:18:35 CPT Camden Property $93.35 -1.6 (-1.69%) 17:18 09/24/18 09/24 17:18 09/24/18 17:18	Camden Property completes acquisition of Florida apartment community Camden Property Trust announced that it has completed the acquisition of a recently constructed 299-home apartment community in Orlando for a total purchase price of approximately $90M. The community is a 9-story high-rise in downtown Orlando built in 2016 featuring a 4th floor pool and amenity deck, 24-hour concierge, retail space and a 3-story parking garage. The community will be renamed Camden Thornton Park and is adjacent to Camden Lake Eola, a new development community which recently started construction.	25 Sep
CPT Camden Property $93.35 -1.6 (-1.69%) 08/14/18 RHCO 08/14/18 NO CHANGE Target $95 RHCO Hold Camden Property price target raised to $95 from $86 at SunTrust SunTrust analyst Michael Lewis raised his price target on Camden Property to $95, saying the company's Q2 saw improved operations in its two biggest markets - Houston and Washington DC. Lewis notes that the strong job growth should allow the Sun Belt REIT market to outperform in the near term, but keeps his Hold rating on Camden Property, adding that its implied valuation of an 8% discount to NAV is already less than the 9% 5-year average. 08/14/18 RBCM 08/14/18 NO CHANGE Target $97 RBCM Outperform Camden Property price target raised to $97 from $92 at RBC Capital RBC Capital analyst Wes Golladay raised his price target on Camden Property to $97 and kept his Outperform rating, citing the company's "healthy organic and external growth along with a well capitalized balance sheet". The analyst states that the accelerated activity in the REIT's top markets of DC and Houston is driving same-store revenue growth of 2.5% and 3.7% respectively, and anticipates the impact from the recent acquisitions to add an "extra layer of growth" for Camden through 2020 05/31/18 GSCO 05/31/18 UPGRADE Target $102 GSCO Conviction Buy Camden Property upgraded to Conviction Buy from Buy at Goldman Sachs Goldman Sachs analyst Andrew Rosivach added Camden Property Trust to his firm's Americas Conviction List while keeping a Buy rating on the shares with a 12-month price target of $102. Recent reports imply U.S. employment growth has stabilized after decelerating from Q1 of 2015 levels, which creates a favorable macro environment for Camden, Rosivach tells investors in a research note. He calls the company a "standout" in multifamily REITs. 03/19/18 UBSW 03/19/18 UPGRADE Target $84 UBSW Neutral Camden Property upgraded to Neutral from Sell at UBS UBS analyst Nicholas Yulico upgraded Camden Property Trust to Neutral while lowering his price target for the shares to $84 from $89. The analyst views the valuation as "more reasonable" at current share levels.

2018-09-24 17:18:35

CPT

Camden Property

$93.35: -1.6 (-1.69%)

17:18

09/24/18

09/24

17:18

09/24/18

17:18

Camden Property completes acquisition of Florida apartment community

Camden Property Trust announced that it has completed the acquisition of a recently constructed 299-home apartment community in Orlando for a total purchase price of approximately $90M. The community is a 9-story high-rise in downtown Orlando built in 2016 featuring a 4th floor pool and amenity deck, 24-hour concierge, retail space and a 3-story parking garage. The community will be renamed Camden Thornton Park and is adjacent to Camden Lake Eola, a new development community which recently started construction.

25
Sep

CPT Camden Property

$93.35: -1.6 (-1.69%)

08/14/18: RHCO

08/14/18: RBCM

05/31/18: GSCO

03/19/18: UBSW

TODAY'S FREE FLY STORIES

ABBV AbbVie $88.01 -1.93 (-2.15%) , ALXN Alexion $125.96 -0.63 (-0.50%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	The ACR and ARHP to hold annual meeting » American College of… American College of Rheumatology & Association of Rheumatology Professionals will hold the 2018 ACR/ARHP Annual Meeting in Chicago on October 19-24. ABBV AbbVie $88.01 -1.93 (-2.15%) ALXN Alexion $125.96 -0.63 (-0.50%) AMGN Amgen $201.75 -1.03 (-0.51%) AUPH Aurinia Pharmaceuticals $5.56 -0.13 (-2.28%) BMY Bristol-Myers $54.31 -1.7 (-3.04%) CELG Celgene $82.42 -0.52 (-0.63%) DGX Quest Diagnostics $102.49 0.12 (0.12%) DNA Bought by RHHBY $0.00 (0.00%) FLXN Flexion $18.96 0.33 (1.77%) GILD Gilead $73.27 -0.9 (-1.21%) GSK GlaxoSmithKline $40.87 1.25 (3.16%) REGN Regeneron $389.94 -5.45 (-1.38%) RARE Ultragenyx $63.33 -0.77 (-1.20%) QDEL Quidel $64.68 -2.85 (-4.22%) PFE Pfizer $44.50 0.48 (1.09%) NVS Novartis $87.19 0.95 (1.10%) MRK Merck $72.34 0.12 (0.17%) MCK McKesson $132.36 -0.34 (-0.26%) LLY Eli Lilly $111.91 -1.4 (-1.24%) TMO Thermo Fisher $227.13 -2.51 (-1.09%) TKPYY Takeda Pharmaceutical $0.00 (0.00%) SELB Selecta Biosciences $13.80 -1.34 (-8.85%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 20 Oct 22 Oct 22 Oct 23 Oct 23 Oct 23 Oct 23 Oct 24 Oct 24 Oct 25 Oct 25 Oct 25 Oct 25 Oct 25 Oct 28 Oct 29 Oct 30 Oct 30 Oct 31 Oct 02 Nov 06 Nov 06 Nov 06 Nov 07 Nov 09 Nov 27 Nov 11 Jan 16 Feb 18 Feb 28 Apr 13 May
ABBV AbbVie $88.01 -1.93 (-2.15%) , DCPH Deciphera $22.22 -4.97 (-18.28%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	European Society for Medical Oncology (ESMO) to hold a conference » ESMO 2018 Congress to be… ESMO 2018 Congress to be held in Munich, Germany on October 19-23. ABBV AbbVie $88.01 -1.93 (-2.15%) DCPH Deciphera $22.22 -4.97 (-18.28%) TSRO Tesaro $41.81 -1.19 (-2.77%) IMGN ImmunoGen $7.44 -0.355 (-4.56%) REGN Regeneron $389.94 -5.45 (-1.38%) CRSP Crispr Therapeutics $36.02 -1.18 (-3.17%) CLVS Clovis $26.41 -3.54 (-11.82%) MRTX Mirati Therapeutics $40.04 -1.82 (-4.35%) LOXO Loxo Oncology $160.01 -7.58 (-4.52%) RHHBY Roche $0.00 (0.00%) NCNA NuCana $18.90 1.9 (11.18%) CRVS Corvus Pharmaceuticals $8.01 -0.1 (-1.23%) NTGN Neon Therapeutics $8.88 0.56 (6.73%) NKTR Nektar $48.23 -1.33 (-2.68%) EXEL Exelixis $16.27 -0.25 (-1.51%) AVEO Aveo Pharmaceuticals $2.50 -0.03 (-1.19%) KURA Kura Oncology $14.38 -1.18 (-7.58%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 20 Oct 22 Oct 22 Oct 24 Oct 28 Oct 30 Oct 01 Nov 01 Nov 02 Nov 02 Nov 06 Nov 07 Nov 10 Nov 26 Nov 27 Nov 24 Dec 14 Jan 28 Apr 13 May
A Agilent $64.47 -1.28 (-1.95%) , AGLE Aeglea BioTherapeutics $9.32 -0.58 (-5.86%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	American Society of Human Genetics to hold a conference » ASHG Conference 2018 will… A Agilent $64.47 -1.28 (-1.95%) AGLE Aeglea BioTherapeutics $9.32 -0.58 (-5.86%) ALXN Alexion $125.96 -0.63 (-0.50%) RHHBY Roche $0.00 (0.00%) BMRN BioMarin $103.31 -0.52 (-0.50%) BIO Bio-Rad $280.96 -3.23 (-1.14%) MSFT Microsoft $108.55 0.01 (0.01%) ILMN Illumina $313.31 -7.98 (-2.48%) FLDM Fluidigm $7.49 -0.45 (-5.67%) HZNP Horizon Pharma $19.07 -0.01 (-0.05%) NVTA Invitae $12.86 -0.23 (-1.76%) NSTG NanoString $15.18 -0.41 (-2.63%) QGEN Qiagen $35.91 0.455 (1.28%) DGX Quest Diagnostics $102.49 0.12 (0.12%) RTRX Retrophin $25.34 0.24 (0.96%) TMO Thermo Fisher $227.13 -2.51 (-1.09%) WTKWY Wolters Kluwer $0.00 (0.00%) ARQL ArQule $4.33 -0.38 (-8.07%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 21 Oct 23 Oct 23 Oct 23 Oct 24 Oct 24 Oct 24 Oct 24 Oct 24 Oct 25 Oct 25 Oct 28 Oct 30 Oct 31 Oct 01 Nov 01 Nov 01 Nov 07 Nov 07 Nov 08 Nov 13 Nov 27 Nov 28 Nov 24 Dec 18 Feb 03 Mar
CLBR Caliburn International $0.00 (0.00%) 18:27 10/19/18 10/19 18:27 10/19/18 18:27 Syndicate	Caliburn International files registration statement for proposed IPO » Caliburn International… Caliburn International announced that it has publicly filed a registration statement on Form S-1 with the SEC related to a proposed initial public offering of Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Caliburn has applied to list its common stock on the New York Stock Exchange under the ticker symbol "CLBR." Jefferies, Merrill Lynch, Pierce, Fenner & Smith Incorporated and SunTrust Robinson Humphrey are serving as joint book-running managers for the offering. Cowen and Company and Raymond James & Associates are acting as co-managers for the proposed offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) 18:10 10/19/18 10/19 18:10 10/19/18 18:10 General news	Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says Reference Link SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CE Celanese $99.62 2.61 (2.69%) 18:02 10/19/18 10/19 18:02 10/19/18 18:02 Hot Stocks	Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe » Celanese announced it… Celanese announced it will increase list and off-list selling prices for Methyl Isobutyl Ketone and Methyl Isobutyl Carbinol by EUR 120 per MT. The price increases below are for orders shipped and will be effective immediately, or as contracts otherwise allow, and are incremental to any previously announced increases. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct
REGN Regeneron $389.94 -5.45 (-1.38%) , SNY Sanofi $44.57 0.12 (0.27%) 17:57 10/19/18 10/19 17:57 10/19/18 17:57 Hot Stocks	Regeneron, Sanofi: FDA approves asthma indication for Dupixent » Regeneron Pharmaceuticals… Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced the U.S. FDA has approved Dupixent as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma. Dupixent inhibits the overactive signaling of interleukin-4 and interleukin-13, two key proteins that contribute to the Type 2 inflammation that may underlie moderate-to-severe asthma. This effect is associated with the reduction of inflammatory biomarkers including fractional exhaled nitric oxide, immunoglobulin E and eotaxin-3. REGN Regeneron $389.94 -5.45 (-1.38%) SNY Sanofi $44.57 0.12 (0.27%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct 19 Oct 20 Oct 23 Oct 28 Oct 29 Oct 06 Nov 28 Jan 22 Mar 28 Apr 13 May
XLE Energy Select Sector SPDR $71.50 -0.67 (-0.93%) , XLU Utilities SPDR $54.57 0.82 (1.53%) … 17:55 10/19/18 10/19 17:55 10/19/18 17:55 General news	Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound » S&P500 SECTORS: … S&P500 SECTORS: Consumer Staples (XLP) up 4.4%... Real Estate (XLRE) up 3.3%... Utilities (XLU) up 3.1%... Financials (XLF) up 0.9%... Communication Services (XLC) up 0.5%... Health Care (XLV) up 0.5%... Industrials (XLI) down 1.0%... Materials (XLB) down 1.2%... Technology (XLK) down 1.2%... Consumer Discretionary (XLY) down 2.0%... Energy (XLE) down 2.0%. COMMODITY: Gold (GLD) up 0.7%... Silver (SLV) flat... Copper (JJCB) down 1.3%... Crude Oil (USO) down 2.7%... Natural Gas (UNG) up 2.9%. FIXED INCOME: High Yield (HYG) down 0.3%... Investment Grade (LQD) down 0.6%... Long-term Treasury (TLT) down 0.7%... Mid-term Treasury (IEF) down 0.2%... Short-term Treasury (SHY) flat. STRATEGY: Value (IWD) up 0.8%... Growth (IWF) down 0.7%. XLE Energy Select Sector SPDR $71.50 -0.67 (-0.93%) XLU Utilities SPDR $54.57 0.82 (1.53%) IYR DJ US Real Estate Index Fund $77.83 0.63 (0.82%) XLP Consumer Staples Sector SPDR $54.72 1.225 (2.29%) XLY Consumer Discretionary Sector SPDR $106.34 -1.06 (-0.99%) XLB S&P Select Materials SPDR $53.13 -0.36 (-0.67%) XLF Financial Select Sector $26.66 0.08 (0.30%) XLV Health Care Select Sector SPDR $91.48 -0.93 (-1.01%) XLK Technology Select Sector SPDR $70.00 -0.04 (-0.06%) XLI Industrial Select Sector SPDR $73.17 -0.31 (-0.42%) GLD SPDR Gold Trust $116.01 0.11 (0.09%) SLV iShares Silver Trust $13.74 0.05 (0.37%) USO United States Oil Fund $14.72 0.155 (1.06%) UNG United States Natural Gas Fund $26.81 0.19 (0.71%) HYG iShares iBoxx $ High Yield Corporate Bond $84.90 0.04 (0.05%) LQD iShares iBoxx $ Investment Grade Corporate Bond $112.69 -0.15 (-0.13%) TLT iShares 20+ Year Treasury Bond Fund $113.73 -0.24 (-0.21%) IEF iShares 7-10 Year Treasury Bond ETF $100.12 -0.12 (-0.12%) SHY iShares 1-3 Year Treasury Bond $82.95 -0.035 (-0.04%) IWD iShares Russell 1000 Value $122.17 0.08 (0.07%) IWF iShares Russell 1000 Growth $145.19 -0.5 (-0.34%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
INSW International Seaways $21.51 0.41 (1.94%) 17:53 10/19/18 10/19 17:53 10/19/18 17:53 Syndicate	Breaking Syndicate news story on International Seaways » International Seaways… International Seaways files $100M mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MNR Monmouth Real Estate $15.49 0.08 (0.52%) 17:48 10/19/18 10/19 17:48 10/19/18 17:48 Hot Stocks	Monmouth Real Estate acquires industrial building in New Jersey for $85.25M » Monmouth Real Estate… Monmouth Real Estate announced the acquisition of a new 347,145 square foot industrial building located in Trenton, New Jersey at a purchase price of $85.25M. The property is net-leased for 15 years with approximately 14 years remaining. The building is situated on approximately 62 acres. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Nov

TEUM Pareteum $2.47 -0.07 (-2.76%) 17:38 10/19/18 10/19 17:38 10/19/18 17:38 Syndicate	Breaking Syndicate news story on Pareteum » Pareteum files to sell… Pareteum files to sell 13.01M shares of common stock for holders 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Nov 15 Nov
TEUM Pareteum $2.47 -0.07 (-2.76%) 17:36 10/19/18 10/19 17:36 10/19/18 17:36 Syndicate	Breaking Syndicate news story on Pareteum » Pareteum files $150M… Pareteum files $150M mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Nov 15 Nov
NOC Northrop Grumman $307.77 -0.445 (-0.14%) , LMT Lockheed Martin $328.22 0.21 (0.06%) … 17:33 10/19/18 10/19 17:33 10/19/18 17:33 Periodicals	Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports » President Donald Trump… President Donald Trump will meet with CEOs of Lockheed Martin (LMT), Boeing (BA), Northrop Grumman (NOC) and General Dynamics (GD) at Luke Air Force Base in Arizona, according to Reuters, citing people familiar with the matter. The group is meeting, for the second time in the past two weeks, to discuss sourcing more parts and materials in the U.S. Executives from BAE Systems (BAESY) and Honeywell (HON) will also be present at the meeting discussing supply chains. Weapons sales to Saudi Arabia were reportedly not on the agenda for the meeting, but the issue could be raised. Reference Link NOC Northrop Grumman $307.77 -0.445 (-0.14%) LMT Lockheed Martin $328.22 0.21 (0.06%) BA Boeing $356.28 -3 (-0.84%) GD General Dynamics $190.43 -0.76 (-0.40%) BAESY BAE Systems $0.00 (0.00%) HON Honeywell $153.49 -1.73 (-1.11%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct 23 Oct 24 Oct 24 Oct 24 Oct 30 Oct
ISR IsoRay $0.50 0.0191 (3.98%) 17:25 10/19/18 10/19 17:25 10/19/18 17:25 Syndicate	Breaking Syndicate news story on IsoRay » IsoRay files to sell… IsoRay files to sell 5.83M shares of common stock for holders 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NHS Neuberger Berman High Yield Strategies Fd $10.55 -0.015 (-0.14%) 17:06 10/19/18 10/19 17:06 10/19/18 17:06 Hot Stocks	Breaking Hot Stocks news story on Neuberger Berman High Yield Strategies Fd » Saba Capital reports… Saba Capital reports 5.15% passive stake in Neuberger Berman High Yield Strategies Fd 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

BIOC Biocept $2.27 -0.04 (-1.73%) 17:04 10/19/18 10/19 17:04 10/19/18 17:04 Syndicate	Breaking Syndicate news story on Biocept » Biocept files to sell… Biocept files to sell 762.4K shares of common stock for holders 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AZO AutoZone $726.10 -4.09 (-0.56%) 17:03 10/19/18 10/19 17:03 10/19/18 17:03 Hot Stocks	AutoZone founder Hyde will not stand for board re-election » AutoZone announced that… AutoZone announced that J. R. "Pitt" Hyde III, a director and the founder of AutoZone, will not stand for re-election to the company's board of directors and will retire from the board in December. "Words cannot express the gratitude I have for Pitt and his vision to create this amazing organization," said Bill Rhodes, Chairman, President and Chief Executive Officer, Customer Satisfaction. "With nearly 40 years of leading AutoZone, Pitt's presence will always remain with our company. From his development of our unique and powerful culture, to his leadership, to teaching us to give back to the city where we live, work and play. We wish Pitt and his wife, Barbara, all the best and we thank both of them for their passionate guidance of AutoZone and philanthropy to Memphis and beyond." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Oct
SACH Sachem Capital $4.33 0.02 (0.46%) 17:03 10/19/18 10/19 17:03 10/19/18 17:03 Syndicate	Breaking Syndicate news story on Sachem Capital » Sachem Capital files… Sachem Capital files $100M mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MRTX Mirati Therapeutics $40.04 -1.82 (-4.35%) 16:53 10/19/18 10/19 16:53 10/19/18 16:53 Conference/Events	Mirati Therapeutics to hold a conference call » Dr. Charles Baum… Dr. Charles Baum discusses the updated Sitravatinib clinical data presented at the 2018 ESMO Annual Meeting on a conference call to be held on October 22 at 8 am. Webcast Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct
SPNE SeaSpine $16.58 -0.54 (-3.15%) 16:47 10/19/18 10/19 16:47 10/19/18 16:47 Hot Stocks	Breaking Hot Stocks news story on SeaSpine » First Light Asset… First Light Asset Management reports 8.8% passive stake in SeaSpine 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

EPZM Epizyme $8.76 -0.04 (-0.45%) 16:46 10/19/18 10/19 16:46 10/19/18 16:46 Conference/Events	Epizyme to hold a conference call » Management discusses the… Management discusses the updated data on Tazemetostat presented at the 2018 ESMO Annual Meeting on a conference call to be held on October 22 at 8:30 am. Webcast Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct
EWI MSCI Italy Index $25.52 0.38 (1.51%) , SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) … 16:40 10/19/18 10/19 16:40 10/19/18 16:40 General news	Breaking General news story on MSCI Italy Index, SPDR S&P 500 ETF Trust, S&P 500 » Moody's cuts Italy… Moody's cuts Italy sovereign rating by one notch to Baa3 with stable outlook EWI MSCI Italy Index $25.52 0.38 (1.51%) SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) SPX S&P 500 $0.00 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ASTC Astrotech $2.93 -0.02 (-0.68%) 16:39 10/19/18 10/19 16:39 10/19/18 16:39 Hot Stocks	Breaking Hot Stocks news story on Astrotech » Winn Interests reports… Winn Interests reports 11.81% passive stake in Astrotech 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CTMX CytomX Therapeutics $15.43 -1.075 (-6.52%) 16:38 10/19/18 10/19 16:38 10/19/18 16:38 Conference/Events	CytomX Therapeutics to host conference call » Management discusses the… Management discusses the clinical presentations presented at the 2018 ESMO Annual Meeting on a conference call to be held on October 22 at 8:30 am. Webcast Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct
ICLK iClick Interactive Asia $3.41 (0.00%) 16:36 10/19/18 10/19 16:36 10/19/18 16:36 Hot Stocks	Breaking Hot Stocks news story on iClick Interactive Asia » LIM Advisors reports… LIM Advisors reports 14.9% passive stake in iClick Interactive Asia 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Fed Bank President Bostic Participates in Community Conversation Government Event

Federal Reserve Bank of Atlanta--1000 Peachtree St. NE, Atlanta, GA
ACN ...
Tomorrow at 00:00

U.S.A. Money 20/20 Conferences

The Venetian, Las Vegas, NV
Tomorrow at 00:00

2018 ACR/ARHP Annual Meeting Conferences

MCormick Place West, Chicago, IL
CLVS ...
Tomorrow at 00:00

ESMO 2018 Congress Conferences

Munich
Tomorrow at 20:30

Technology: Hardware--China Industry Meetings
2018-10-22 at 00:00

2018 ACR/ARHP Annual Meeting Conferences

MCormick Place West, Chicago, IL
CRVS ...
2018-10-22 at 00:00

ESMO 2018 Congress Conferences

Munich
2018-10-22 at 00:00

U.S.A. Money 20/20 Conferences

The Venetian, Las Vegas, NV
2018-10-22 at 00:00

26th Annual Symposium of Office of International Affairs Conferences

CFTC Headquarters--1155 21st Street, NW, Washington, D.C.
ACN ...
2018-10-22 at 00:00

Oracle OpenWorld Conference 2018 Conferences

San Francisco, CA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	SIBN X SIBN SI-BONE IPO Managers: Morgan Stanley & BofA/Merrill, Canaccord, JMP Securities Priced at: $15.00 7.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVU X CVU CPI Aerostructures Secondary Managers: Canaccord & B. Riley FBR Priced at: $6.25 2.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	MSC X MSC Studio City IPO Managers: Deutsche Bank, Credit Suisse & Morgan Stanley Priced at: $12.50 28.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSMT X OSMT Osmotica Pharmaceuticals IPO Managers: Jefferies, Barclays & RBC Capital, Wells Fargo Priced at: $7.00 6.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHAS X PHAS PhaseBio IPO Managers: Citi, Cowen & Stifel, Needham Priced at: $5.00 9.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VJET X VJET voxeljet Secondary Managers: Piper Jaffray Priced at: $2.57 4.86M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Leerink & Evercore ISI Priced at: $10.75 8.645M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	LOGC X LOGC LogicBio Therapeutics IPO Managers: Jefferies, Barclays & William Blair, Chardan Priced at: $10.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NIU X NIU Niu Technologies IPO Managers: Credit Suisse & Citi, Needham Priced at: $9.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWI X SWI SolarWinds IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley & Credit Suisse, MLCO, Barclays, Citi, Evercore ISI, Jefferies, Macquarie, Nomura Instinet, RBC Capital, Baird, JMP Securities, KeyBanc, Mischler, Ramirez, SunTrust Priced at: $15.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRYS X KRYS Krystal Biotech Secondary Managers: Cowen, William Blair & Cantor Fitzgerald, Chardan, Ladenburg Priced at: $20.00 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Oppenheimer Priced at: $4.25 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAP X INAP Internap Spot Secondary Managers: Jefferies & Credit Suisse Priced at: $9.50 4.21M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	REPX X REPX Riley Exploration IPO Managers: SunTrust & Seaport Global, Capital One, Imperial Capital, Roth Capital $14.00-16.00 6.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VTEC X VTEC Valtech SE IPO Managers: JPMorgan & Morgan Stanley, Cowen, William Blair, Oddo BHF SCA $14.00-16.00 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Camden Property completes acquisition of Florida apartment community

TODAY'S FREE FLY STORIES

Get Full Fly Access